Lawmakers Seek To Examine Biosimilars Law Progress
This article was originally published in Scrip
Executive Summary
The House Energy and Commerce Subcommittee on Health wants to look under the hood and see how things are going with the FDA's progress in implementing the 2010 law that gave the agency the authority to approve biosimilars – Biologics Price Competition and Innovation Act (BPCIA) – and plans to convene a Feb. 4 hearing.